Nikolai Novikov
Gilead Sciences (Australia)(AU)
Publications by Year
Research Areas
Hepatitis B Virus Studies, Hepatitis C virus research, HIV Research and Treatment, HIV/AIDS drug development and treatment, Neonatal Respiratory Health Research
Most-Cited Works
- → Clinical targeting of HIV capsid protein with a long-acting small molecule(2020)403 cited
- → PD-1 blockade partially recovers dysfunctional virus–specific B cells in chronic hepatitis B infection(2018)271 cited
- → A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model(2019)160 cited
- → New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action(2012)159 cited
- → Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ(2015)153 cited
- → The KN-93 Molecule Inhibits Calcium/Calmodulin-Dependent Protein Kinase II (CaMKII) Activity by Binding to Ca2+/CaM(2019)114 cited
- → Impact of Primary Elvitegravir Resistance-Associated Mutations in HIV-1 Integrase on Drug Susceptibility and Viral Replication Fitness(2013)110 cited
- → Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B(2019)92 cited
- → Hepatitis B core-specific memory B cell responses associate with clinical parameters in patients with chronic HBV(2020)62 cited
- → 2,4,6-Triaminopyrimidine as a Novel Hinge Binder in a Series of PI3Kδ Selective Inhibitors(2016)47 cited